153 related articles for article (PubMed ID: 34452478)
1. Special Issue "APOBECs and Virus Restriction".
Chelico L
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452478
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like Gene Expression, RNA Editing, and MicroRNAs Regulation.
Cao W; Wu W
Methods Mol Biol; 2018; 1699():75-81. PubMed ID: 29086369
[TBL] [Abstract][Full Text] [Related]
3. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
He X; Li J; Wu J; Zhang M; Gao P
Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
[TBL] [Abstract][Full Text] [Related]
4. AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19.
Meshcheryakova A; Pietschmann P; Zimmermann P; Rogozin IB; Mechtcheriakova D
Front Immunol; 2021; 12():690416. PubMed ID: 34276680
[TBL] [Abstract][Full Text] [Related]
5. AID/APOBEC-like cytidine deaminases are ancient innate immune mediators in invertebrates.
Liu MC; Liao WY; Buckley KM; Yang SY; Rast JP; Fugmann SD
Nat Commun; 2018 May; 9(1):1948. PubMed ID: 29769532
[TBL] [Abstract][Full Text] [Related]
6. APOBECs and virus restriction.
Harris RS; Dudley JP
Virology; 2015 May; 479-480():131-45. PubMed ID: 25818029
[TBL] [Abstract][Full Text] [Related]
7. Live-Cell Quantification of APOBEC1-Mediated RNA Editing: A Comparison of RNA Editing Assays.
Chieca M; Torrini S; Conticello SG
Methods Mol Biol; 2021; 2181():69-81. PubMed ID: 32729075
[TBL] [Abstract][Full Text] [Related]
8. Insights into the Structures and Multimeric Status of APOBEC Proteins Involved in Viral Restriction and Other Cellular Functions.
Chen XS
Viruses; 2021 Mar; 13(3):. PubMed ID: 33802945
[No Abstract] [Full Text] [Related]
9. Epitranscriptomic profiling across cell types reveals associations between APOBEC1-mediated RNA editing, gene expression outcomes, and cellular function.
Rayon-Estrada V; Harjanto D; Hamilton CE; Berchiche YA; Gantman EC; Sakmar TP; Bulloch K; Gagnidze K; Harroch S; McEwen BS; Papavasiliou FN
Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13296-13301. PubMed ID: 29167373
[TBL] [Abstract][Full Text] [Related]
10. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
Hersberger M; Patarroyo-White S; Qian X; Arnold KS; Rohrer L; Balestra ME; Innerarity TL
Biochem J; 2003 Jan; 369(Pt 2):255-62. PubMed ID: 12374571
[TBL] [Abstract][Full Text] [Related]
11. C-to-U RNA Editing: From Computational Detection to Experimental Validation.
Lerner T; Kluesner M; Tasakis RN; Moriarity BS; Papavasiliou FN; Pecori R
Methods Mol Biol; 2021; 2181():51-67. PubMed ID: 32729074
[TBL] [Abstract][Full Text] [Related]
12. A systems biology analysis of protein-protein interactions in the APOBEC family.
Wang Y; Chen G; Yang Y; Hu Z; Chen X
Life Sci; 2008 Oct; 83(15-16):521-30. PubMed ID: 18793652
[TBL] [Abstract][Full Text] [Related]
13. Effect of apolipoprotein B mRNA-editing catalytic polypeptide-like protein-3G in cervical cancer.
Xu Y; Leng J; Xue F; Dong R
Int J Clin Exp Pathol; 2015; 8(10):12307-12. PubMed ID: 26722417
[TBL] [Abstract][Full Text] [Related]
14. Distribution and difference of APOBEC-induced mutations in the TpCpW context of HBV DNA between HCC and non-HCC.
Ren F; Li W; Xiang A; Wang L; Li M; Guo Y
J Med Virol; 2020 Jan; 92(1):53-61. PubMed ID: 31429946
[TBL] [Abstract][Full Text] [Related]
15. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
MacGinnitie AJ; Anant S; Davidson NO
J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
Oka K; Kobayashi K; Sullivan M; Martinez J; Teng BB; Ishimura-Oka K; Chan L
J Biol Chem; 1997 Jan; 272(3):1456-60. PubMed ID: 8999814
[TBL] [Abstract][Full Text] [Related]
17. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
[TBL] [Abstract][Full Text] [Related]
18. DNA Editing by APOBECs: A Genomic Preserver and Transformer.
Knisbacher BA; Gerber D; Levanon EY
Trends Genet; 2016 Jan; 32(1):16-28. PubMed ID: 26608778
[TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48.
Hirano K; Young SG; Farese RV; Ng J; Sande E; Warburton C; Powell-Braxton LM; Davidson NO
J Biol Chem; 1996 Apr; 271(17):9887-90. PubMed ID: 8626621
[TBL] [Abstract][Full Text] [Related]
20. RNA editing of BFP, a point mutant of GFP, using artificial APOBEC1 deaminase to restore the genetic code.
Bhakta S; Sakari M; Tsukahara T
Sci Rep; 2020 Oct; 10(1):17304. PubMed ID: 33057101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
